Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

111 results

Sort by

List item

Human medicine European public assessment report (EPAR): Rilonacept Regeneron (previously Arcalyst)

Rilonacept, Cryopyrin-Associated Periodic Syndromes
Date of authorisation: 23/10/2009, , Revision: 5, Withdrawn, Last updated: 30/10/2012
List item

Human medicine European public assessment report (EPAR): Rivastigmine Teva

rivastigmine, Dementia; Alzheimer Disease; Parkinson Disease
Date of authorisation: 17/04/2009, , Revision: 4, Withdrawn, Last updated: 27/09/2012
List item

Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma GmbH

clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009, , Revision: 1, Withdrawn, Last updated: 26/07/2012
List item

Human medicine European public assessment report (EPAR): Clopidogrel Hexal

clopidogrel, Peripheral Vascular Diseases; Acute Coronary Syndrome; Myocardial Infarction; Stroke
Date of authorisation: 28/07/2009, , Revision: 2, Withdrawn, Last updated: 26/07/2012
List item

Human medicine European public assessment report (EPAR): Clopidogrel Acino Pharma

clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009, , Revision: 1, Withdrawn, Last updated: 26/07/2012
List item

Human medicine European public assessment report (EPAR): Docefrez

docetaxel, Stomach Neoplasms; Adenoma; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Prostatic Neoplasms
Date of authorisation: 10/05/2010, , Revision: 1, Withdrawn, Last updated: 14/06/2012
List item

Human medicine European public assessment report (EPAR): Xigris

drotrecogin alfa (activated), Sepsis; Multiple Organ Failure
Date of authorisation: 22/08/2002, , Revision: 13, Withdrawn, Last updated: 21/02/2012
List item

Human medicine European public assessment report (EPAR): Clopidogrel Sandoz

clopidogrel, Peripheral Vascular Diseases; Stroke; Myocardial Infarction
Date of authorisation: 21/09/2009, , Revision: 2, Withdrawn, Last updated: 26/10/2011
List item

Human medicine European public assessment report (EPAR): Onsenal

Celecoxib, Adenomatous Polyposis Coli
Date of authorisation: 17/10/2003, , Revision: 13, Withdrawn, Last updated: 06/04/2011
List item

Human medicine European public assessment report (EPAR): Clopidogrel 1A Pharma

clopidogrel, Peripheral Vascular Diseases
Date of authorisation: 28/07/2009, , Revision: 1, Withdrawn, Last updated: 28/02/2011
List item

Human medicine European public assessment report (EPAR): Duzallo

allopurinol, lesinurad, Gout
Date of authorisation: 23/08/2018, , Revision: 2, Withdrawn, Last updated: 06/08/2020